Generally, the impact of POLE mutation on the whole EC cells and tumor microenvironment is intricate and complex, including not only the activation or infiltration of CD8+ T and CD4+ T cells or the abnormal expression of PD-L1 and other genes but also the alteration of gene expression patterns or signaling pathways. The gene discussed is CD4; the disease is neoplasm.